Veterinary Bacteriology: General Medical Microbiology 1 – Flashcards
Unlock all answers in this set
Unlock answersdistinguish prokaryotes from eukaryotes |
prokaryotes: no nucleus or membrane bound organelles less than 5 microns in size 70s ribosomes (eukaryotes 80s except in organelles which have 70s) nucleic acid is a single circular molecule replicate by binary fission
|
Gram negative cell walls |
thin peptidoglycan layer have outer membrane and periplasmic space (pps) porins transport hydrophilic molecules in/out of pps LPS and lipid A major surface antigen stain red or pink: lose crystal violet and get safranin red
|
Gram positive cell walls |
thick peptidoglycan teichoic acids - major surface antigen stain purple: retain crystal violet |
Gram stain |
1) crystal violet 2) gram's iodine - form complex in cells that have crystal violet 3) decolorizer (ex alcohol) 4) safranin red |
Lipopolysaccharide |
Lipid A - endotoxin activity core polysaccharide: link Lipid A to terminal PS, maintain cell wall integrity terminal PS: repeating sugar subunits; O antigen |
bacterial cell membrane properties |
no sterols (few exceptions: mycoplasma) no organelles: cell membrane takes over these processes (respiration, making macromolecules) |
Capsules |
AKA glycocalyx, exopolysaccharide, slime layer hydophilic, gel like simple polysaccharide covering aid in identification avoid phagocytic recognition weak immunogen can allow growth of microbial communities
|
fimbriae |
hair-like filamentous structures that extend outward through the capsular layer anchor bacteria to solid surfaces outer part: single repeating protein subunit Additional fimbrial proteins are required for membrane transport, anchoring to the cell wall, filament assembly
|
flagella |
filamentous structures that extend outward from the cell to function in motility single repeating protein subunit, flagellin Additional proteins are involved in hook and basal body structures which anchor the flagellum to the cell wall and generate motion |
endospores |
made by bacillus and clostridium extreme resistance: dipicolinic acid, high levels of Parts: core: contains components of live cell inner membrane: semi crystalline, becomes fluid after germination. surrounded by thin PG layer cortex: modified PG, special glycosidic bonds resist lysozyme, no teichoic acids or carbs coat: impermeable to enzymes exosporium: thin, complex membrane on outside ; ; ; |
endospore germination |
takes several minutes end dormancy: physical damage to the exosporium germination is initiated by loss of dipicolinic Outgrowth through the spore coat and cell division: when nutrients are present |
endospore sporulation |
cell dies and releases an endospore takes 8-10 hours |
log phase growth |
cells rapidly reproduce produce metabolic enzymes find growth rate by measuring colonies, or possibly spectrophotometry of samples, over time "population doubling time" if new nutrients are added and toxic products are removed in a steady-state, bacteria can, theoretically, A laboratory device used to obtain a steady-state of |
pathogenic bacteria: nutrient source |
tend to use macromolecules such as starch, proteins; don't produce own food source |
selective differential and selective enrichment media |
Selective-enrichment and selective-differential media both select for a particular type of bacteria. Selective-differential media differs in that it also contains some substance, such as a pH indicator, to assist in determining the identity of the bacteria.
|
types of oxygen requirements |
Obligate aerobes microaerophilic bacteria capnophilic bacteria: carbon dioxide also must be high aerotolerant facultative anaerobes obligate anaerobes |
reactive oxygen species (toxic oxygen radicals) |
Superoxide, singlet oxygen, peroxides found: where metabolism is occuring; especially high in phagolysosomes Bacteria use enzymes (oxidase, catalase, superoxide dismutase) to convert them into less dangerous forms.
|
food storage methods to retard microbial growth |
Refrigeration, freezing, treating with acid or salt, drying. Heating, radiation, and preservatives are intended to kill bacteria.
|
3 elements of biosafety |
Procedures (hand-washing) equipment (gloves) facilities (double sets of doors, autoclaves, security)
|
classification of infectious agents, risk |
virulence and therapy groups: 1 – unlikely to cause disease. 2 – associated with non-serious disease, treatment available. 3 – associated with serious disease, treatment sometimes available. 4 – likely to cause serious disease, treatment unavailable or disease difficult to treat. risk to individual and community: 1 – low risk. 2 – moderate individual risk. 3 – high individual risk, low community risk. 4 – high individual and community risk.
|
test sensitivity |
likelihood (%) of true positives found by your test. |
test specificity |
likelihood (%) of true negatives found by your test. |
positive predictive value |
represents how likely a positive result is to be a true positive varies with prevalence of the disease in the population
|
negative predictive value |
represents how likely a negative result is to be a true negative.
|
preanalytical stage of testing |
Proper test selection proper sample collection labeling storage transport |
methods to detect microbes in animal samples |
Direct – Gross or microscopic Gram stain and acid fast stain Serology / fluorescent antibody molecular analysis: PCR and DNA restriction comparisons.
|
using humoral / immune response in lab testing |
Serology (ELISA testing) skin hypersensitivity testing lymphocyte proliferation cytokine production assays Limitations: you have to know what you’re testing for. not cheap enough to test for everything at once some combined tests are available (e.g. Snap Tests for lyme, ehrlichia, and heartworm).
|
antibiotics: natural source and purpose |
naturally produced by fungi and bacteria purpose: "secondary metabolites" - not certain vestiges of normal metabolism could be used for signalling |
rate kinetics of antibiotics |
1st order rate kinetics, i.e. one molecule of drug is consumed by one target molecule. maintaining an optimal proportion of drug to target is important for treatment.
|
major subcellular targets of antibiotics and an example for each |
Cell wall – beta lactams (penicillin)
Cell membrane – polymixin
Ribosomal action – tetracyclines (doxycycline)
Nucleic Acid: sulfonamides (sulfamethazine) - folic acid synth metronidazole - DNA structure Quinolones (enrofloxacin) - DNA gyrase
|
two methods for susceptibility testing |
Diffusion: diffuse drug through agar to form a gradient of drug concentrations ex: disc diffusion Dilution: contain uniform concentrations of drug in a broth or agar medium ex: microbroth diluton |
disc diffusion: endpoint measured |
diameter of zone of inhibition compare to standard values for organism to classify as Susceptible, Intermediate or Resistant |
broth dilution: endpoint measured |
visible growth MIC is reported as lowest concentration where all growth is inhibited |
standardization factors for testing susceptibility |
composition of medium ions / pH depth and volume concentration of drug disk size and material incubation time and conditions preparation of inoculum, concentration organism used criteria for endpoints
|
susceptible |
high likelihood of therapeutic success
|
intermediate |
therapeutic outcome is uncertain |
resistant |
High likelihood of therapeutic failure |
how to determine resistance or susceptibility |
MIC or zone diameter values compared to published “breakpoint” guidelines
|
Guidelines for drug/organism/host combination: determining factors |
|
selective toxicity |
the ability to kill or slow the growth of microbes while minimizing harm to the infected host |
therapeutic index |
the lethality (in animal studies) divided by the effective dose values are found for 50% of a representative population (LD50 and ED50) high therapeutic index: drugs that are able to target a part of the bacteria not present or important in the host ex: cell wall synthesis / beta lactams
|
bactericidal |
kills bacteria ex: beta lactams (must have active growth) cephalosporins |
bacteriostatic |
slows the growth of bacteria without killing ex: tetracyclines, sulfonamides |
factors for selecting an antimicrobial agent for treatment |
1. species/age related adverse effects 2. fixed compounding (size/concentration/carrier) 3. restraint/feeding habits 4. compatibility with other medications 5. propensity for antimicrobial resistance |
factors that affect efficacy of treatment besides MIC result |
1. physiological status of the bacteria (ex growth phase) 2. immuno-physiological status of the host 3. pharmacokinetic properties of drug in host (effect of host on drug - absorption, distribution, elimination, binding) 4. pharmacodynamic properties of drug (effect of drug on host/bacteria – principle of selective toxicity, post-antibiotic effect, sub-MIC effects, immunosuppression) |
plasmids |
small, circular peices of DNA do not code essential functions or products Conjugative plasmids are self-transmissible from one bacterium to another in the process called conjugation Some non-conjugative plasmids can be mobilized by conjugative plasmids, others cannot plamids are replicated when the cell divides, can be integrated in the chromosome |
lytic bacterial infection |
Recognition Injection Transcription of phage DNA replication & protein synthesis phage assembly lysis and release |
transformation |
small, extracellular DNA fragments free DNA is rapidly degraded in extracellular environments and DNA is a large macromolecule that does not normally cross cell membranes. competent cells are able to bind the DNA, translocate accross membrane and integrate into its chromosome within one species bacteria die and others are able to pick up their DNA to get that function occurs in a limited number of pathogens; mostly within same species |
Transduction |
moderate gene capacity a DNA fragment is assembled in a bacteriophage nucleocapsid during lytic infection Transduction occurs in different bacterial species but is limited by host range of the transducing phage
|
conjugation |
moderate to large gene capacity unidirectional plasmid transfer from a suitable donor to a recipient bacterial cell encodes sex pilus so the recipient can go on to transfer it again
|
integrons |
site-specific recombination systems that recognize sites on 2 DNAs and promote the insertion of new DNA. The most common integrons possess an antimicrobial resistance gene. Integrons are important factors in multiple antimicrobial resistance in Gram-negative bacteria. |
transposons |
may move by excision from one location and insertion into another or by replication at one site and insertion of a new copy elsewhere. sometimes referred to as jumping genes, can move large distances between DNA regions within a cell, eg. between plasmids and chromosome. Many transposons possess genes for other traits such as antimicrobial resistance. insertion may result in inactivation of genes in the target DNA region |
insertion sequences |
genetic elements that are capable of moving, in a random fashion,from one place in a DNA molecule to another through site specific recombination Each has terminal invert repeat sequences that encode enzymes for excision (transposase) and insertion (recombinase) and is flanked by direct repeats of the target sequence following insertion. Insertion sequences are always excised from one region of DNA and inserted into another. Insertion sequences do not move great distances and do not usually carry selectable genes. |
aquired resistance methods |
1. Altered Targets (reduced drug binding affinity) 2. Enzymatic Inactivation of Drug (modifying enzymes ex beta lactamases) 3. Decreased Cell Permeability (porins, OMPs) (changes in LPS and outer membrane proteins can increase resistance to certain drugs) 4. Decreased Accumulation of Drug in Cell (efflux, antiport systems) |
innate resistance methods |
a. structure b. alternate pathways c. environmentally regulated phenotypic variation |
solutions to antibiotic resistance issues |
1. Prudent drug use restrict extra label use, alternative therapy 2.Pathogen Control hygeine, vaccination, food safety, understanding resistance methods 3. Policy education, resisitance monitoring
|
Koch's Postulates |
;1) microbe must be associated with sick animals and not with healthy ones.; 2) grow a pure culture of the microbe.; 3) Infect a new host with the microbe and see disease take hold.; 4) isolate the same microbe again from the new host.;; ;;Limitations: some microbes are opportunistic (so they appear in healthy as well as sick hosts), not all microbes can be cultured, in culture the microbes could lose their virulence.;; multi-species disease ; a disease caused by the interaction of two or more parasitic microbe species. ; |
epidemiological triad |
host: species, age, breed, sex, genetics, physiology, immune ;pathogen: virulence, stability, route, dose ;environment: stress, nutrition, trauma, immunosuppression, metabolic dysfunction, intercurrent disease, cilmate |
3 Types of virulence factors |
|
Colonization |
1. enable a bacterium to reach a site of entry (bacterial motility and chemotaxis) 2. hold bacteria in place at the site of entry (bacterial adhesins ; fimbriae, non-fimbrial surface proteins, biofilm-forming exopolysaccharides) 3. support sufficient growth at the site of entry (preferred substrates, iron sequestering components ; siderophores, lactoferrin/transferring/heme receptors) Colonization can involve complex relationships with other microorganisms. |
Avoiding destruction after invasion |
; possession of iron sequestering components (meet nutrient requirements) avoiding destruction by host phagocytic cells and serum proteins: 1. evade phagocytosis; 2. destroy or inactivate phagocytes; 3. protect bacteria from phagocytic killing by escape from phagocytic vacuoles, prevention of lysosomal fusion to phagosomes or resistance to hydrolysis in phagolysosomes.; ; |
tissue destruction methods |
; Toxins: act directly with mechanical or physiological alterations in cells; act indirectly by triggering exaggerated host inflammatory/immunological responses that cause tissue damage ; |
AB model toxin |
1) a;requirement for unfolding through enzymatic ;nicking; to activate toxin; 2) functional;domains (binding and catalytic activity) that are physically separable either as different proteins or different termini of a single protein. |